Your Shopping Cart Is Empty
| ✷ Report Code: A01623 | Apr 2022 | Pages: 172 | ||
| Tables: 114 | Charts: 52 |
| |
The global spine bone stimulators market size was valued at $487.80 million in 2020, and is projected to reach $665.55 million by 2030, growing at a CAGR of 3.2% from 2021 to 2030.
Bone stimulator is a crucial and spinal fusion procedure, which is used to enhance the bone’s healing process. A bone stimulator, may be internal or external, is a small device that delivers low-voltage electrical currents directly to the spinal area where bone growth (spine fusion) is about to occur. Typically, these devices are worn after spine fusion. Spine bone stimulator is used during a spinal fusion. Spine bone stimulators are used during a spinal fusion surgery along with spinal instrumentation (plates, rods, and screws) and bone grafts. These stimulators send low-level electrical signals to the fusion site, in turn activating the body's natural bone healing process, which gets impaired in at-risk patients and preventing delayed unions or non-union of the spine fractures.
The COVID-19 outbreak is anticipated to have a negative impact on growth of the global Spine Bone Stimulator market. The COVID-19 pandemic stressed healthcare systems globally. In 2020, the diagnosis and treatment of spinal injury was hampered by the COVID-19 pandemic, as it reduced in road traffic accidents and outdoor sport activities. Reduction in planned surgeries also hampered the market.
The key factors that drive the spine bone stimulators market growth include factors such as rise in the incidence of spinal cord disorder. According to report given by united spinal association in August 2020, there are approximately 296,000 Americans currently living with spinal cord injury, and about 17,900 new spinal cord injury cases are reported each year and about 78% of new spinal cord injury cases are male. According to spine bone stimulators market analysis, surge in geriatric population boost the spine bone stimulators market growth. For instance, as per report share by Bloomberg quint in August 2020, the old age dependency ratio has increased. That ratio has surged from 14.2% in 2011 to 15.7% in 2021 as per projections. It is expected to rise to 20.1% by 2031. In addition, rise in awareness of newly developed technologies and upsurge in healthcare expenditure have significantly boosted the market growth.
There are some restraints for the spine bone stimulators industry, which are availability substitute, fixation instrumentation during fusion & non-union fractures, and high initial cost of these devices.
Rapid escalation in geriatric population, increase in incidence of spinal deformities, and upsurge in need for adequate healthcare facilities are expected to drive the demand for spinal bone stimulators in the near future. In addition, emerging nations need to focus on cost-effectiveness and scalability to caterto the needs of the growing patient pool.
The spine bone stimulators market size is segmented on the basis of device type, end user, and region. On the basis of device type, the market is bifurcated into non-invasive spine bone stimulator and invasive spine bone stimulators. Non-invasive spine bone stimulator is further divided into pulsed electromagnetic field (PEMF) device and capacitive coupling (CC) &combined magnetic field (CMF) devices. By end user, the market is divided into hospital, specialty clinic, and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment review
Depending on device type, non-invasive spine bone stimulator segment was the highest contributor to the market in 2020, and this trend is expected to continue during the forecast period, as external bone growth stimulation devices are worn outside the skin, typically after spinefusion, and do not require surgical implantation or extraction and cause less complication. However, the same segment is anticipated to witness considerable growth during the forecast period.
On the basis of end user, hospital segment was the highest contributor to the market in 2020, and this trend is expected to continue during the spine bone stimulators market forecast period, due to rise in the number of orthopedic procedure in the hospital.
Region-wise, North America dominated held the largest spine bone stimulators market share in 2020, and is expected to be dominant during the forecast period, owing to surge in the geriatric population, rise in patient awareness about reliable spine fusion surgeries, and growth in incidence of spinal disorders such as osteoporosis &arthritis that boost the spinal bone stimulators markets.
However, Asia-Pacific is expected to register highest CAGR of 5.1% during spine bine stimulartors market forecast, owing to rise in geriatric population base, presence of large pool of patients, increase in disposable incomes, and rise in patient awareness about advancing spinal disorders-related surgeries. In addition, awareness initiatives by various governments and private organizations also fuel this growth.
The major companies profiled in this report include Enovis (DJO Global, Inc.), Zimmer Biomet. Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, Orchid Medical, Inc., IGEA S.p.A., ManaMed Inc., Theragen, Inc. Intelligent Implants              Â
Spine Bone Stimulators Market Report Highlights
| Aspects | Details |
|---|---|
| By Device Type |
|
| By End User |
|
| By Region |
|
| Key Market Players | IGEA S.p.A. , ManaMed Inc., Orchid Medical, Inc., Theragen, Inc., Intelligent Implants, Ossatec Benelux BV, Zimmer Biomet, Elizur Corporation, Orthofix Medical Inc., Enovis (DJO Global, Inc.) |
CHAPTER 1: Â INTRODUCTION
1.1.Report Description
1.2.Key Market Segments
1.3.Key Benefits
1.4.Research Methodology
1.4.1.Primary Research
1.4.2.Secondary Research
1.4.3.Analyst Tools and Models
CHAPTER 2: Â EXECUTIVE SUMMARY
2.1.CXO Perspective
CHAPTER 3: Â MARKET LANDSCAPE
3.1.Market Definition and Scope
3.2.Key Findings
3.2.1.Top Investment Pockets
3.2.2.Top Winning Strategies
3.3.Porter's Five Forces Analysis
3.3.1.Bargaining Power of Suppliers
3.3.2.Threat of New Entrants
3.3.3.Threat of Substitutes
3.3.4.Competitive Rivalry
3.3.5.Bargaining Power among Buyers
3.4.Market Share Analysis/Top Player Positioning
3.4.1. Market Share Analysis/Top Player Positioning 2020
3.5.Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. Â COVID-19 Impact Analysis
CHAPTER 4: Â SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE
4.1.Market Overview
 4.1.1Market Size and Forecast, By Device Type
4.2. Invasive Spine Bone Stimulators
4.2.1.Key Market Trends, Growth Factors and Opportunities
4.2.2.Market Size and Forecast, By RegionÂ
4.2.3.Market Share Analysis, By Country
4.3. Non-Invasive Spine Bone Stimulators
4.3.1.Key Market Trends, Growth Factors and Opportunities
4.3.2.Market Size and Forecast, By RegionÂ
4.3.3.Market Share Analysis, By Country
4.3.4.Pulsed Electromagnetic Field (PEMF) Devices
4.3.4.1.Market Size and Forecast
4.3.5.Capacitive Coupling (CC) and Combined Magnetic Field (CMF) Devices
4.3.5.1.Market Size and Forecast
CHAPTER 5: Â SPINE BONE STIMULATORS MARKET, BY END USER
5.1.Market Overview
5.1.1Market Size and Forecast, By End User
5.2. Hospitals
5.2.1.Key Market Trends, Growth Factors and Opportunities
5.2.2.Market Size and Forecast, By RegionÂ
5.2.3.Market Share Analysis, By Country
5.3. Specialty Clinics
5.3.1.Key Market Trends, Growth Factors and Opportunities
5.3.2.Market Size and Forecast, By RegionÂ
5.3.3.Market Share Analysis, By Country
5.4. Others
5.4.1.Key Market Trends, Growth Factors and Opportunities
5.4.2.Market Size and Forecast, By RegionÂ
5.4.3.Market Share Analysis, By Country
CHAPTER 6: Â SPINE BONE STIMULATORS MARKET, BY REGION
6.1.Market Overview
6.1.1Market Size and Forecast, By Region
6.2.North America
6.2.1.Key Market Trends and Opportunities
6.2.2.Market Size and Forecast, By Device Type
6.2.3.Market Size and Forecast, By End User
6.2.4.Market Size and Forecast, By Country
6.2.5.United States Spine Bone Stimulators Market
6.2.5.1.Market Size and Forecast, By Device Type
6.2.5.2.Market Size and Forecast, By End User
6.2.6.Canada Spine Bone Stimulators Market
6.2.6.1.Market Size and Forecast, By Device Type
6.2.6.2.Market Size and Forecast, By End User
6.2.7.Mexico Spine Bone Stimulators Market
6.2.7.1.Market Size and Forecast, By Device Type
6.2.7.2.Market Size and Forecast, By End User
6.3.Europe
6.3.1.Key Market Trends and Opportunities
6.3.2.Market Size and Forecast, By Device Type
6.3.3.Market Size and Forecast, By End User
6.3.4.Market Size and Forecast, By Country
6.3.5.France Spine Bone Stimulators Market
6.3.5.1.Market Size and Forecast, By Device Type
6.3.5.2.Market Size and Forecast, By End User
6.3.6.Germany Spine Bone Stimulators Market
6.3.6.1.Market Size and Forecast, By Device Type
6.3.6.2.Market Size and Forecast, By End User
6.3.7.Italy Spine Bone Stimulators Market
6.3.7.1.Market Size and Forecast, By Device Type
6.3.7.2.Market Size and Forecast, By End User
6.3.8.Spain Spine Bone Stimulators Market
6.3.8.1.Market Size and Forecast, By Device Type
6.3.8.2.Market Size and Forecast, By End User
6.3.9.U.K Spine Bone Stimulators Market
6.3.9.1.Market Size and Forecast, By Device Type
6.3.9.2.Market Size and Forecast, By End User
6.3.10.Rest Of Europe Spine Bone Stimulators Market
6.3.10.1.Market Size and Forecast, By Device Type
6.3.10.2.Market Size and Forecast, By End User
6.4.Asia-Pacific
6.4.1.Key Market Trends and Opportunities
6.4.2.Market Size and Forecast, By Device Type
6.4.3.Market Size and Forecast, By End User
6.4.4.Market Size and Forecast, By Country
6.4.5.China Spine Bone Stimulators Market
6.4.5.1.Market Size and Forecast, By Device Type
6.4.5.2.Market Size and Forecast, By End User
6.4.6.Japan Spine Bone Stimulators Market
6.4.6.1.Market Size and Forecast, By Device Type
6.4.6.2.Market Size and Forecast, By End User
6.4.7.India Spine Bone Stimulators Market
6.4.7.1.Market Size and Forecast, By Device Type
6.4.7.2.Market Size and Forecast, By End User
6.4.8.South Korea Spine Bone Stimulators Market
6.4.8.1.Market Size and Forecast, By Device Type
6.4.8.2.Market Size and Forecast, By End User
6.4.9.Australia Spine Bone Stimulators Market
6.4.9.1.Market Size and Forecast, By Device Type
6.4.9.2.Market Size and Forecast, By End User
6.4.10.Rest of Asia Pacific Spine Bone Stimulators Market
6.4.10.1.Market Size and Forecast, By Device Type
6.4.10.2.Market Size and Forecast, By End User
6.5.LAMEA
6.5.1.Key Market Trends and Opportunities
6.5.2.Market Size and Forecast, By Device Type
6.5.3.Market Size and Forecast, By End User
6.5.4.Market Size and Forecast, By Country
6.5.5.Brazil Spine Bone Stimulators Market
6.5.5.1.Market Size and Forecast, By Device Type
6.5.5.2.Market Size and Forecast, By End User
6.5.6.South Africa, Spine Bone Stimulators Market
6.5.6.1.Market Size and Forecast, By Device Type
6.5.6.2.Market Size and Forecast, By End User
6.5.7.Saudi Arabia Spine Bone Stimulators Market
6.5.7.1.Market Size and Forecast, By Device Type
6.5.7.2.Market Size and Forecast, By End User
6.5.8.Rest of LAMEA Spine Bone Stimulators Market
6.5.8.1.Market Size and Forecast, By Device Type
6.5.8.2.Market Size and Forecast, By End User
CHAPTER 7: Â COMPANY PROFILES
7.1. Enovis (DJO Global, Inc.)
7.1.1.Company Overview
7.1.2.Key Executives
7.1.3.Company snapshot
7.1.4.Operating business segments
7.1.5.Product portfolio
7.1.6.Business Performance
7.1.7.Key Strategic Moves and Developments
7.2. Zimmer Biomet
7.2.1.Company Overview
7.2.2.Key Executives
7.2.3.Company snapshot
7.2.4.Operating business segments
7.2.5.Product portfolio
7.2.6.Business Performance
7.2.7.Key Strategic Moves and Developments
7.3. Orthofix Medical Inc.
7.3.1.Company Overview
7.3.2.Key Executives
7.3.3.Company snapshot
7.3.4.Operating business segments
7.3.5.Product portfolio
7.3.6.Business Performance
7.3.7.Key Strategic Moves and Developments
7.4. Elizur Corporation
7.4.1.Company Overview
7.4.2.Key Executives
7.4.3.Company snapshot
7.4.4.Operating business segments
7.4.5.Product portfolio
7.4.6.Business Performance
7.4.7.Key Strategic Moves and Developments
7.5. Ossatec Benelux BV
7.5.1.Company Overview
7.5.2.Key Executives
7.5.3.Company snapshot
7.5.4.Operating business segments
7.5.5.Product portfolio
7.5.6.Business Performance
7.5.7.Key Strategic Moves and Developments
7.6. Orchid Medical, Inc.
7.6.1.Company Overview
7.6.2.Key Executives
7.6.3.Company snapshot
7.6.4.Operating business segments
7.6.5.Product portfolio
7.6.6.Business Performance
7.6.7.Key Strategic Moves and Developments
7.7. IGEA S.p.A.Â
7.7.1.Company Overview
7.7.2.Key Executives
7.7.3.Company snapshot
7.7.4.Operating business segments
7.7.5.Product portfolio
7.7.6.Business Performance
7.7.7.Key Strategic Moves and Developments
7.8. ManaMed Inc.
7.8.1.Company Overview
7.8.2.Key Executives
7.8.3.Company snapshot
7.8.4.Operating business segments
7.8.5.Product portfolio
7.8.6.Business Performance
7.8.7.Key Strategic Moves and Developments
7.9. Theragen, Inc.
7.9.1.Company Overview
7.9.2.Key Executives
7.9.3.Company snapshot
7.9.4.Operating business segments
7.9.5.Product portfolio
7.9.6.Business Performance
7.9.7.Key Strategic Moves and Developments
7.10. Intelligent Implants
7.10.1.Company Overview
7.10.2.Key Executives
7.10.3.Company snapshot
7.10.4.Operating business segments
7.10.5.Product portfolio
7.10.6.Business Performance
7.10.7.Key Strategic Moves and Developments
Note: *Details on financial performance and strategic moves and developments may not be captured for
 unlisted companies.
 *List of companies profiled in this TOC is tentative and may change after detailed analysis.
 *Market size and forecast will be provided from 2020-2030, and forecast period would be 2021-2030.
 *The provided information and segments are for representation purpose only. The actual information
 delivered would change significantly as per findings during the course of study and upon its
 completion.
LIST OF TABLES
TABLE 1.GLOBAL SPINE BONE STIMULATORS MARKET, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 2.GLOBAL SPINE BONE STIMULATORS MARKET FOR INVASIVE SPINE BONE STIMULATORS, BY REGION, 2020-2030 ($MILLION)
TABLE 3.GLOBAL SPINE BONE STIMULATORS MARKET FOR NON-INVASIVE SPINE BONE STIMULATORS, BY REGION, 2020-2030 ($MILLION)
TABLE 4.GLOBAL SPINE BONE STIMULATORS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 5.GLOBAL SPINE BONE STIMULATORS MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
TABLE 6.GLOBAL SPINE BONE STIMULATORS MARKET FOR SPECIALTY CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 7.GLOBAL SPINE BONE STIMULATORS MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 8.GLOBAL SPINE BONE STIMULATORS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 9.NORTH AMERICA SPINE BONE STIMULATORS, BY Region, 2020-2030 ($MILLION)
TABLE 10.NORTH AMERICA SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 11.NORTH AMERICA SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 12.UNITED STATES SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 13.UNITED STATES SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 14.CANADA SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 15.CANADA SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 16.MEXICO SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 17.MEXICO SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 18.EUROPE SPINE BONE STIMULATORS, BY Region, 2020-2030 ($MILLION)
TABLE 19.EUROPE SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 20.EUROPE SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 21.FRANCE SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 22.FRANCE SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 23.GERMANY SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 24.GERMANY SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 25.ITALY SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 26.ITALY SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 27.SPAIN SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 28.SPAIN SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 29.UNITED KINGDOM SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 30.UNITED KINGDOM SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 31.REST OF EUROPE SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 32.REST OF EUROPE SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 33.ASIA-PACIFIC SPINE BONE STIMULATORS, BY Region, 2020-2030 ($MILLION)
TABLE 34.ASIA-PACIFIC SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 35.ASIA-PACIFIC SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 36.CHINA SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 37.CHINA SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 38.JAPAN SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 39.JAPAN SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 40.INDIA SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 41.INDIA SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 42.SOUTH KOREA SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 43.SOUTH KOREA SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 44.AUSTRALIA SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 45.AUSTRALIA SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 46.REST OF ASIA PACIFIC SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 47.REST OF ASIA PACIFIC SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 48.LAMEA SPINE BONE STIMULATORS, BY Region, 2020-2030 ($MILLION)
TABLE 49.LAMEA SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 50.LAMEA SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 51.BRAZIL SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 52.BRAZIL SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 53.SOUTH AFRICA, SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 54.SOUTH AFRICA, SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 55.SAUDI ARABIA SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 56.SAUDI ARABIA SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 57.REST OF LAMEA SPINE BONE STIMULATORS, BY DEVICE TYPE, 2020-2030 ($MILLION)
TABLE 58.REST OF LAMEA SPINE BONE STIMULATORS, BY END USER, 2020-2030 ($MILLION)
TABLE 59.ENOVIS (DJO GLOBAL, INC.): KEY EXECUTIVES
TABLE 60.ENOVIS (DJO GLOBAL, INC.): COMPANY SNAPSHOT
TABLE 61.ENOVIS (DJO GLOBAL, INC.): OPERATING SEGMENTS
TABLE 62.ENOVIS (DJO GLOBAL, INC.): PRODUCT PORTFOLIO
TABLE 63.ENOVIS (DJO GLOBAL, INC.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 64.ZIMMER BIOMET: KEY EXECUTIVES
TABLE 65.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 66.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 67.ZIMMER BIOMET: PRODUCT PORTFOLIO
TABLE 68.ZIMMER BIOMET: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 69.ORTHOFIX MEDICAL INC.: KEY EXECUTIVES
TABLE 70.ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT
TABLE 71.ORTHOFIX MEDICAL INC.: OPERATING SEGMENTS
TABLE 72.ORTHOFIX MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 73.ORTHOFIX MEDICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 74.ELIZUR CORPORATION: KEY EXECUTIVES
TABLE 75.ELIZUR CORPORATION: COMPANY SNAPSHOT
TABLE 76.ELIZUR CORPORATION: OPERATING SEGMENTS
TABLE 77.ELIZUR CORPORATION: PRODUCT PORTFOLIO
TABLE 78.ELIZUR CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79.OSSATEC BENELUX BV: KEY EXECUTIVES
TABLE 80.OSSATEC BENELUX BV: COMPANY SNAPSHOT
TABLE 81.OSSATEC BENELUX BV: OPERATING SEGMENTS
TABLE 82.OSSATEC BENELUX BV: PRODUCT PORTFOLIO
TABLE 83.OSSATEC BENELUX BV: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84.ORCHID MEDICAL, INC.: KEY EXECUTIVES
TABLE 85.ORCHID MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 86.ORCHID MEDICAL, INC.: OPERATING SEGMENTS
TABLE 87.ORCHID MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 88.ORCHID MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89.IGEA S.P.A. : KEY EXECUTIVES
TABLE 90.IGEA S.P.A. : COMPANY SNAPSHOT
TABLE 91.IGEA S.P.A. : OPERATING SEGMENTS
TABLE 92.IGEA S.P.A. : PRODUCT PORTFOLIO
TABLE 93.IGEA S.P.A. : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94.MANAMED INC.: KEY EXECUTIVES
TABLE 95.MANAMED INC.: COMPANY SNAPSHOT
TABLE 96.MANAMED INC.: OPERATING SEGMENTS
TABLE 97.MANAMED INC.: PRODUCT PORTFOLIO
TABLE 98.MANAMED INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99.THERAGEN, INC.: KEY EXECUTIVES
TABLE 100.THERAGEN, INC.: COMPANY SNAPSHOT
TABLE 101.THERAGEN, INC.: OPERATING SEGMENTS
TABLE 102.THERAGEN, INC.: PRODUCT PORTFOLIO
TABLE 103.THERAGEN, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104.INTELLIGENT IMPLANTS: KEY EXECUTIVES
TABLE 105.INTELLIGENT IMPLANTS: COMPANY SNAPSHOT
TABLE 106.INTELLIGENT IMPLANTS: OPERATING SEGMENTS
TABLE 107.INTELLIGENT IMPLANTS: PRODUCT PORTFOLIO
TABLE 108.INTELLIGENT IMPLANTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1.GLOBAL SPINE BONE STIMULATORS MARKET SEGMENTATION
FIGURE 2.GLOBAL SPINE BONE STIMULATORS MARKET
FIGURE 3.SEGMENTATION SPINE BONE STIMULATORS MARKET
FIGURE 4.TOP INVESTMENT POCKET IN SPINE BONE STIMULATORS MARKET
FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
FIGURE 11.LOW THREAT OF SUBSTITUTION
FIGURE 12.HIGH COMPETITIVE RIVALRY
FIGURE 13.TOP PLAYER POSITIONING, 2020
FIGURE 14.MARKET SHARE ANALYSIS, 2020
FIGURE 15.RESTRAINTS AND DRIVERS: SPINE BONE STIMULATORS MARKET
FIGURE 16.SPINE BONE STIMULATORS MARKET SEGMENTATION, BY DEVICE TYPE
FIGURE 17.SPINE BONE STIMULATORS MARKET FOR INVASIVE SPINE BONE STIMULATORS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 18.SPINE BONE STIMULATORS MARKET FOR NON-INVASIVE SPINE BONE STIMULATORS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 19.SPINE BONE STIMULATORS MARKET SEGMENTATION, BY END USER
FIGURE 20.SPINE BONE STIMULATORS MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 21.SPINE BONE STIMULATORS MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 22.SPINE BONE STIMULATORS MARKET FOR OTHERS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 23.ENOVIS (DJO GLOBAL, INC.): NET SALES, 2018-2020 ($MILLION)
FIGURE 24.ENOVIS (DJO GLOBAL, INC.): REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 25.ENOVIS (DJO GLOBAL, INC.): REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 26.ZIMMER BIOMET: NET SALES, 2018-2020 ($MILLION)
FIGURE 27.ZIMMER BIOMET: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 28.ZIMMER BIOMET: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 29.ORTHOFIX MEDICAL INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 30.ORTHOFIX MEDICAL INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 31.ORTHOFIX MEDICAL INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 32.ELIZUR CORPORATION: NET SALES, 2018-2020 ($MILLION)
FIGURE 33.ELIZUR CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 34.ELIZUR CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 35.OSSATEC BENELUX BV: NET SALES, 2018-2020 ($MILLION)
FIGURE 36.OSSATEC BENELUX BV: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 37.OSSATEC BENELUX BV: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 38.ORCHID MEDICAL, INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 39.ORCHID MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 40.ORCHID MEDICAL, INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 41.IGEA S.P.A. : NET SALES, 2018-2020 ($MILLION)
FIGURE 42.IGEA S.P.A. : REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 43.IGEA S.P.A. : REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 44.MANAMED INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 45.MANAMED INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 46.MANAMED INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 47.THERAGEN, INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 48.THERAGEN, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 49.THERAGEN, INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 50.INTELLIGENT IMPLANTS: NET SALES, 2018-2020 ($MILLION)
FIGURE 51.INTELLIGENT IMPLANTS: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 52.INTELLIGENT IMPLANTS: REVENUE SHARE, BY REGION, 2020 (%)
This section provides the opinions of the CXOs of the companies operating in the global spine bone stimulators market. Spinal disorders, such as spinal stenosis, spondylolisthesis, and scoliosis, are on a continuous rise globally; thus, the development of effective spine bone stimulators is required for a successful spine fusion surgery. This surgery makes use of spine bone stimulators to prevent delayed unions of the vertebral fractures. On the basis of interviews conducted, the adoption of spine bone stimulators is expected to increase in near future due to advancements in surgical options, rise in geriatric population, and increase in incidence rate of spinal disorders.
As per the CXOs, Asia-Pacific possesses high market potential, especially in emerging economies (such as China & India) owing to surge in healthcare expenditure and growth in geriatric population coupled with high incidence of spine impairments.
A. Growing preference towards non-invasive spine bone stimulators is an upcoming trend observed in the market
A. Spine bone stimulators are used in spinal fusion procedures to enhance the bone healing process
A. North America is the largest regional market for spine bone stimulators
A. The estimated industry size of spine bone stimulator was $ 487.80 million in 2020 and is anticipated to reach at $ 665.55 million by 2030
A. Enovis (DJO Global, Inc.), Zimmer Biomet, Orthofix Medical Inc., are top companies operating in spine bone stimulators market
Start reading instantly.
This Report and over 66,965+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report